Circulating levels of copeptin, a novel biomarker in pre-eclampsia

ZULFIKAROGLU E., ISLIMYE M., TONGUC E. A. , PAYASLI A., Isman F. K. , VAR T., et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, cilt.37, ss.1198-1202, 2011 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 37 Konu: 9
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1111/j.1447-0756.2010.01498.x
  • Dergi Adı: JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
  • Sayfa Sayısı: ss.1198-1202

Özet

Aims: Increasing evidence supports the participation of metabolic syndrome and insulin resistance in the pathogenesis of pre-eclampsia. Copeptin is co-synthesized with vasopressin and is a new and promising novel marker of metabolic syndrome and insulin resistance. Our aim was to investigate copeptin levels in normotensive pregnant, mild and severe pre-eclamptic women.